DiaMedica Therapeutics Inc — Dividend History & Yield (NASDAQ:DMAC) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Nouvelles

Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock

DiaMedica to conduct additional study for preeclampsia treatment

Cisco, Flutter, Manulife and more set to report earnings Wednesday

DiaMedica Therapeutics : TD Cowen initie une couverture avec une recommandation d’achat

DiaMedica Therapeutics stock initiated with Buy rating at TD Cowen

Tracking Leon Cooperman’s ~$3B Omega Advisors Portfolio – Q2 2025 Update

DiaMedica Therapeutics, Inc. (DMAC) is a Great Momentum Stock: Should You Buy?

After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright

Wall Street Analysts Believe DiaMedica Therapeutics (DMAC) Could Rally 100.81%: Here's is How to Trade

What Makes DiaMedica Therapeutics, Inc. (DMAC) a Strong Momentum Stock: Buy Now?

Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect?

DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia (NASDAQ:DMAC)